菏泽鲁西新区：筑牢用药安全防线 赋能产业高质量发展

Core Viewpoint - The Heze Luxi New Area has made significant progress in drug safety regulation and industry development, addressing public concerns and enhancing safety awareness through various initiatives [1][5]. Group 1: Drug Safety Regulation - The Luxi New Area has implemented a dual approach of "promotion + training" to enhance public and industry personnel's safety awareness, conducting multiple public outreach events and training sessions [2]. - A comprehensive regulatory system has been established, focusing on risk management and local oversight, with over 1,600 law enforcement personnel deployed to inspect 463 drug operating units this year [3]. - The "Code for Assurance" platform has achieved a 100% registration rate for drug operating units, ensuring traceability and quality control of drugs [3]. Group 2: Industry Development - The biopharmaceutical industry is a key sector in the Luxi New Area, with several major projects completed and new investments signed, totaling 7.51 billion yuan this year [4]. - The area has facilitated the growth of retail pharmacy chains, with 282 drug retail enterprises and a chain rate of 86%, promoting scale and efficiency in the industry [5]. Group 3: Public Engagement and Compliance - The Luxi New Area has strengthened online drug sales regulation, achieving a 100% inspection coverage of 149 online sales enterprises, while advising consumers to purchase from legitimate platforms [5]. - Future efforts will focus on enhancing regulatory services and encouraging public participation in drug safety governance, fostering a collaborative environment for high-quality industry development [5].